Æȷοì
Katharine Elizabeth Stott
Katharine Elizabeth Stott
Clinical PhD Fellow, medical doctor, University of Liverpool/ Malawi Liverpool Wellcome Trust
liverpool.ac.ukÀÇ À̸ÞÀÏ È®ÀεÊ
Á¦¸ñ
Àοë
Àοë
¿¬µµ
Therapeutic drug monitoring for invasive mould infections and disease: pharmacokinetic and pharmacodynamic considerations
KE Stott, WW Hope
Journal of Antimicrobial Chemotherapy 72 (suppl_1), i12-i18, 2017
1102017
Pharmacokinetics of rifampicin in adult TB patients and healthy volunteers: a systematic review and meta-analysis
KE Stott, H Pertinez, MGG Sturkenboom, MJ Boeree, R Aarnoutse, ...
Journal of Antimicrobial Chemotherapy 73 (9), 2305-2313, 2018
932018
Evidence for expanding the role of streptomycin in the management of drug-resistant Mycobacterium tuberculosis
KA Cohen, KE Stott, V Munsamy, AL Manson, AM Earl, AS Pym
Antimicrobial agents and chemotherapy 64 (9), 10.1128/aac. 00860-20, 2020
422020
AMBIsome Therapy Induction OptimisatioN (AMBITION): high dose ambisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a phase 3 ¡¦
DS Lawrence, N Youssouf, SF Molloy, A Alanio, M Alufandika, ...
Trials 19, 1-13, 2018
412018
Res. 127 (1997) 302;(b) K. Stott, J. Stonehouse, J. Keeler, T.-L. Hwang, AJ Shaka
K Stott
J. Am. Chem. Soc 117, 4199, 1995
371995
Cryptococcal meningoencephalitis: time for action
KE Stott, A Loyse, JN Jarvis, M Alufandika, TS Harrison, HC Mwandumba, ...
The Lancet Infectious Diseases 21 (9), e259-e271, 2021
332021
Population pharmacokinetics and cerebrospinal fluid penetration of fluconazole in adults with cryptococcal meningitis
KE Stott, J Beardsley, R Kolamunnage-Dona, AS Castelazo, FM Kibengo, ...
Antimicrobial agents and chemotherapy 62 (9), 10.1128/aac. 00885-18, 2018
202018
Managing potential drug-drug interactions between gastric acid-reducing agents and antiretroviral therapy: experience from a large HIV-positive cohort
JM Lewis, KE Stott, D Monnery, K Seden, NJ Beeching, M Chaponda, ...
International journal of STD & AIDS 27 (2), 105-109, 2016
202016
Implementing antiretroviral resistance testing in a primary health care HIV treatment programme in rural KwaZulu-Natal, South Africa: early experiences, achievements and challenges
RJ Lessells, KE Stott, J Manasa, KK Naidu, A Skingsley, T Rossouw, ...
BMC Health Services Research 14, 1-10, 2014
202014
Clostridium difficile: A healthcare-associated infection of unknown significance in adults in sub-Saharan Africa
AJ Keeley, NJ Beeching, KE Stott, P Roberts, A Watson, MJ Beadsworth
Malawi Medical Journal 28 (2), 66-69, 2016
192016
Out of sight, out of mind? The psychosocial needs of children formerly associated with armed forces: a case study of Save the children UK's work in Beni and Lubero territories ¡¦
K Stott
The International Journal of Health Planning and Management 24 (S1), S52-S72, 2009
192009
Pharmacokinetics of orally administered voriconazole in African penguins (Spheniscus demersus) after single and multiple doses
MW Hyatt, NP Wiederhold, WW Hope, KE Stott
Journal of zoo and wildlife medicine 48 (2), 352-362, 2017
172017
Pharmacokinetics–pharmacodynamics of antifungal agents in the central nervous system
KE Stott, W Hope
Expert Opinion on Drug Metabolism & Toxicology 14 (8), 803-815, 2018
152018
Southern African Treatment Resistance Network (SATuRN) RegaDB HIV drug resistance and clinical management database: supporting patient management, surveillance and research in ¡¦
J Manasa, R Lessells, T Rossouw, K Naidu, C Van Vuuren, D Goedhals, ...
Database 2014, bat082, 2014
102014
Brief report: virologic monitoring can be a cost-effective strategy to diagnose treatment failure on first-line ART
AM Vandormael, DR Boulware, FC Tanser, TW Bärnighausen, KE Stott, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 71 (4), 462-466, 2016
92016
Population pharmacokinetic model and meta-analysis of outcomes of amphotericin B deoxycholate use in adults with cryptococcal meningitis
KE Stott, J Beardsley, S Whalley, FM Kibengo, NTH Mai, NLN Tùng, ...
Antimicrobial agents and chemotherapy 62 (7), 10.1128/aac. 02526-17, 2018
82018
Sensitivity of SARS-CoV-2 RNA polymerase chain reaction using a clinical and radiological reference standard
AJ Stockdale, F Fyles, C Farrell, J Lewis, D Barr, K Haigh, M Abouyannis, ...
Journal of Infection 82 (6), 260-268, 2021
72021
Combined antiretroviral and antituberculosis drug resistance following incarceration
KE Stott, T De Oliviera, RJ Lessells
Southern African journal of HIV medicine 14 (3), 135-137, 2013
62013
Population pharmacokinetics and pharmacodynamics of itraconazole for disseminated infection caused by Talaromyces marneffei
KE Stott, T Le, T Nguyen, S Whalley, J Unsworth, VT Ly, ...
Antimicrobial agents and chemotherapy 65 (11), 10.1128/aac. 00636-21, 2021
52021
Population pharmacokinetics and CSF penetration of flucytosine in adults with HIV-associated cryptococcal meningoencephalitis
KE Stott, A Ahmadu, C Kajanga, M Moyo, E Gondwe, W Chimang¡¯anga, ...
Journal of Antimicrobial Chemotherapy 78 (4), 1015-1022, 2023
32023
ÇöÀç ½Ã½ºÅÛÀÌ ÀÛµ¿µÇÁö ¾Ê½À´Ï´Ù. ³ªÁß¿¡ ´Ù½Ã ½ÃµµÇØ ÁÖ¼¼¿ä.
ÇмúÀÚ·á 1–20